Keywords: مهار کننده هیستون داسیدلاز; Valproic acid; Histone deacetylase inhibitor; Proteomics; Posttranslational modification; Hemorrhage; Traumatic brain injury;
مقالات ISI مهار کننده هیستون داسیدلاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده هیستون داسیدلاز; Circadian rhythm; Transcription; Histone deacetylase inhibitor; Glucocorticoids;
Keywords: مهار کننده هیستون داسیدلاز; Peroxisome; Cancer; Pexophagy; Plasmalogen; Mitochondrion; Metabolism; AA; arachidonic acid; ABCD; ATP-binding cassette (ABC) transporters subfamily D; ACOX; Acyl Coenzyme-A oxidase; AGPS; alkyl-glycerone phosphate synthase; AMACR; α-Methylacyl-CoA racem
Keywords: مهار کننده هیستون داسیدلاز; ARV-825 PubChem CID 92044400; BETd-246 PubChem CID 131698640; dBET1 PubChem CID 91799313; I-BET151 PubChem CID 52912189; I-BET762 PubChem CID 46943432; JQ1 PubChem CID 46907787; MS417 PubChem CID 59190723; OTX015 PubChem CID 9936746; THZ1 PubChem CID 7360
Keywords: مهار کننده هیستون داسیدلاز; HDACi; histone deacetylase inhibitor; HDAC; histone deacetylase; SCFA; short-chain fatty acids; GSTs; glutathione-S transferases; NRP-1; Neuropilin-1; P-gp; P-glycoprotein; CI; combination index; Butyrate; Colorectal cancer; Dietary fiber; Synergistic eff
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; 2-aminobenzamides; Dithiocarbamate; Antiproliferation; Molecular docking;
Keywords: مهار کننده هیستون داسیدلاز; Acute myeloid leukemia; Myelodysplastic syndrome; Hypomethylating agent; Histone deacetylase inhibitor;
Keywords: مهار کننده هیستون داسیدلاز; 5mC; 5- hydroxymethylcytosine; AML; acute myeloid leukemia; BET; bromodomain inhibitors; CCOC; clear cell ovarian cancer; ctDNA; cell-free tumor DNA; ChIP-on-chip; chromatin immunoprecipitation with DNA microarray; CIMP; CpG island methylator phenotype; C
Keywords: مهار کننده هیستون داسیدلاز; Arsenic; Cell Malignant Transformation; Histone Acetylation and Methylation; LC-MS/MS Based Histone Modification Analysis; ac; Acetyl/Acetylated; AGC; Automatic Gain Control; BCa; Bladder Cancer; CID; Collision-Induced Dissociation; DTT; Dithiothreitol; I
Keywords: مهار کننده هیستون داسیدلاز; Tendon stem/progenitor cells; Scleraxis; Stem cell phenotype; Histone deacetylation; Histone deacetylase inhibitor; Cell sheet;
Keywords: مهار کننده هیستون داسیدلاز; Histone acetylation; Histone deacetylase inhibitor; Trichostatin A; Electrospun aligned fibers; Tendon differentiation; Tissue regeneration;
Keywords: مهار کننده هیستون داسیدلاز; Breast cancer; Valproic acid; Histone deacetylase inhibitor; Endocrine therapy; Epigenetic modulators;
Keywords: مهار کننده هیستون داسیدلاز; ac; acetylation; BET; bromodomain and extra terminal family proteins; BMP7; bone morphogenic protein 7; BRD4; bromodomain-containing protein 4; bp; base pairs; CKD; chronic kidney disease; CTGF; connective tissue growth factor; DDR; DNA damage response; D
Keywords: مهار کننده هیستون داسیدلاز; Transgene expression; Artificial histone acetyltransferase; Plasmid DNA; Chromatin immunoprecipitation; Histone deacetylase inhibitor;
Keywords: مهار کننده هیستون داسیدلاز; Cardiac fibrosis; DNA methylation; Histone deacetylase inhibitor; Anti-miRNA; Dietary epigenetic compounds;
Keywords: مهار کننده هیستون داسیدلاز; TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: مهار کننده هیستون داسیدلاز; BAL; bronchoalveolar lavage; ChIA-PET; chromatin interaction analysis with paired-end tag; ChIP-seq; chromatin inmunoprecipitation and massively parallel sequencing; circ-ncRNA; circulating noncoding RNA; CRC; colorectal cancer; CRISPR-Cas9; clustered, re
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Benzohydroxamic acid; HDAC6; HDAC8;
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Hydroxamates; 2-Aminobenzamides; Antiproliferation; Molecular docking;
Anticancer properties of sodium selenite in human glioblastoma cell cluster spheroids
Keywords: مهار کننده هیستون داسیدلاز; 3D culture; Three dimension cell culture; ABC; ATP-binding cassette; ANOVA; analysis of variance; AOBS; Acousto-Optical Beam Splitter; APMA; amino-phenyl mercuric acetate; BBB; blood brain barrier; BSA; bovine serum albumin; CA9; carbonic anhydrase 9; DME
Keywords: مهار کننده هیستون داسیدلاز; GD; Gaucher disease; LSDs; lysosomal storage disorders; GLD; globoid cell leukodystrophy; IDS; iduronate-2-sulfatase; MPS IVA; Mucopolysaccharidosis type IVA; NPC; Niemann-Pick disease type C; GALNS; N-acetylgalactosamine-6-sulfate sulfatase; AGU; Asparty
Keywords: مهار کننده هیستون داسیدلاز; Duchenne muscular dystrophy; Givinostat; Histone deacetylase inhibitor; Histology; Clinical trial;
Keywords: مهار کننده هیستون داسیدلاز; CTCL; Cutaneous T-cell lymphoma; Cutaneous tumors; Histone deacetylase inhibitor; Pruritus;
Keywords: مهار کننده هیستون داسیدلاز; HDACi; histone deacetylase inhibitor; GPR; G-protein coupled receptor; BMMC; bone marrow derived mast cells; SCFA; short chain fatty acid; Ac-H3K9; acetylated histone 3 lysine 9; TSA; trichostatin A; BSA; bovine serum albumin; PARP; poly (ADP-ribose) poly
Keywords: مهار کننده هیستون داسیدلاز; Principal component analysis; Feature extraction; Contextual fear conditioning; Histone deacetylase inhibitor;
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; IMiD; Refractory relapse; Relapsed/refractory;
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase; Histone deacetylase inhibitor; Isoform-specific; K560; Parkinson's disease; Neurodegeneration; MPTP;
Keywords: مهار کننده هیستون داسیدلاز; Ca2+ channel; K+ channel; Ca2+-activated Clâ channel; Transcription; Pre-mRNA splicing; Protein degradation; AD; Alzheimer's disease; ADPR; ADP ribose; AITC; allyl isothiocyanate; AKAP; A-kinase anchoring protein; AMPK; 5â² AMP-activated protein kinase
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Neuropathic pain; Morphine
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Suberoylanilide hydroxamic acid; Poly-d, l-lactide-co glycolide; Nanoprecipitation; A549 cells; Antineoplastic;
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; LPS; Liver; Inflammation; Apoptosis
Keywords: مهار کننده هیستون داسیدلاز; Polymeric nanoparticle; Epigenetic inhibitor; Drug delivery; Controlled release; Stimuli-responsive; ADCA; adenocarcinoma; BrD; bromodomain; BRET; bioluminescence resonance energy transfer; DDS; drug delivery system; DLS; dynamic light scattering; DMF; di
Keywords: مهار کننده هیستون داسیدلاز; Vorinostat; Insulin-like growth factor receptor; Histone deacetylase inhibitor; Drug resistance;
Keywords: مهار کننده هیستون داسیدلاز; Non-Small Cell Lung Cancer; Cisplatin; Drug resistance; Histone deacetylase inhibitor
Keywords: مهار کننده هیستون داسیدلاز; ADX; adrenalectomized; ASD; autism spectrum disorders; BD; bipolar disorder; CSF; cerebrospinal fluid; DAMPs; damage-associated molecular patterns; FS; forced swimming; HDACi; histone deacetylase inhibitor; HSP; heat shock protein; IDO; indoleamine 2,3 di
Keywords: مهار کننده هیستون داسیدلاز; Dog; Cloning; SCNT; Suberoylanilide hydroxamic acid; Histone deacetylase inhibitor;
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylases; Histone deacetylases inhibitors; Heart failure; Hypertrophy; DOCA; deoxycorticosterone acetate; HAT; histone acetyltransferases; HDAC; histone deacetylase; HDACi; histone deacetylase inhibitor; MEF2; myocyte enhancer factor-2; MITR;
Keywords: مهار کننده هیستون داسیدلاز; Non-small cell lung cancer; Epidermal growth factor receptor; Histone deacetylase inhibitor; Epigenetics; Clinical trial; Erlotinib; Romidepsin;
Keywords: مهار کننده هیستون داسیدلاز; α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Keywords: مهار کننده هیستون داسیدلاز; HDACi; Histone Deacetylase Inhibitor; Largazole; Class I Histone Deacetylase Inhibitor; Pyridine analogs; Cytotoxic and biochemical assays;
Keywords: مهار کننده هیستون داسیدلاز; Traumatic brain injury; Hemorrhagic shock; Histone deacetylase inhibitor; Fresh frozen plasma; Neuroprotection; Platelet activation; Resuscitation; Swine
Keywords: مهار کننده هیستون داسیدلاز; DC; dyskeratosis congenita; DOXO; doxorubicin; HDACi; histone deacetylase inhibitor; TSA; trichostatin A; CQ; chloroquine; SAH; senescence-associated heterochromatinization; Senescence-associated heterochromatinization; Dyskeratosis congenita; DNA damage;
Keywords: مهار کننده هیستون داسیدلاز; Cholesterol; Oxysterol; CYP46A1; CYP27A1; CYP3A4; CYP39A1; CYP7B1; CH25H; Cholesterol 7α-hydroxylase; Sterol 27-hydroxylase; Cholesterol 24-hydroxylase; Cholesterol 25-hydroxylase; Oxysterol 7α-hydroxylase; 24-hydroxycholesterol 7α-hydroxylase; Epigene
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Somatic cell nuclear transfer; Valproic acid; In vivo development; In vitro development;
Keywords: مهار کننده هیستون داسیدلاز; BDNF; brain derived neurotrophic factor; CAMKII; calmodulin-dependent protein kinase II; Ca2+; calcium; cAMP; cyclic adenosine monophosphate; CBS; cystathionine-β-synthase; CCI; chronic constriction injury; CFA; complete Freund's adjuvant; cGMP; cyclic
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Cancer; Apoptosis; Cell cycle
Histone deacetylase inhibition-mediated neuronal differentiation via the Wnt signaling pathway in human adipose tissue-derived mesenchymal stem cells
Keywords: مهار کننده هیستون داسیدلاز; Histone deacetylase inhibitor; Neuronal differentiation; Adipose tissue-derived stem cell; Wnt; JNK; GSK3b;
Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells
Keywords: مهار کننده هیستون داسیدلاز; Triple negative breast cancers; PARP inhibitor; Histone deacetylase inhibitor; Homologous recombination; BRCA1 mutated cells;
An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma
Keywords: مهار کننده هیستون داسیدلاز; Epigenetics; Histone deacetylase inhibitor; PANORAMA; Safety; Subcutaneous BTZ;
HDAC11 is a regulator of diverse immune functions
Keywords: مهار کننده هیستون داسیدلاز; APC; antigen presenting cell; CTCL; cutaneous T-cell lymphoma; DAMP; Damage associated molecular pattern; DC; dendritic cell; FDA; U.S. Food and Drug Administration; GVHD; graft versus host disease; HAT; histone acetyltransferase; HDAC; histone deacetylas